Table 2.
Comparison of schizophrenia and bipolar disorder polygenic risk scores between patients with psychotic disorders and controlsa
Polygenic risk score | Polygenic risk score P-value thresholds | |||
---|---|---|---|---|
5 × 10−08 | 1 × 10−04 | 0.05 | 1 | |
Schizophrenia | ||||
P-value | 1.3 × 10−06 | 6.8 × 10−21 | 7.6 × 10−40 | 5.7 × 10−40 |
Variance explained, % | 1.1 | 4.4 | 9 | 9 |
Bipolar disorder | ||||
P-value | 0.6 | 0.25 | 2.8 × 10−09 | 5.7 × 10−11 |
Variance explained, % | <0.1 | <0.1 | 1.7 | 2.1 |
Schizophrenia polygenic risk scores and bipolar disorder polygenic risk scores were calculated using as reference, respectively, the outcome of the schizophrenia and bipolar disorder mega-analyses conducted by the Psychiatric Genomics Consortium. We then compared the scores between 1168 case participants and 1472 controls using standard logistic regression at ten different P-value thresholds (PT 5 × 10−08, 1 × 10−06, 1 × 10−04, 1 × 10−03, 0.01, 0.05, 0.1, 0.2, 0.5, 1). Regression models included the first three ancestry-based principal components and a cohort indicator as covariates. For clarity, here we report P-values and the variance explained in disease risk as measured by Nagelkerke's pseudo-R2 at four P-value thresholds (PT 5 × 10−08, 1 × 10−04, 0.05, 1). Results at each one of the ten different thresholds are available in Supplementary Table 6.